Status:
COMPLETED
How Can we Treat Photophobia in Migraine
Lead Sponsor:
Medical University of Vienna
Collaborating Sponsors:
Austrian Science Fund (FWF)
Conditions:
Migraine Disorders
Photophobia
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Photophobia, the aberrantly increased sensitivity to light, is a common symptom in migraine patients and light discomfort is frequently found as a trigger for migraine attacks. In behavioral studies, ...
Eligibility Criteria
Inclusion
- Patients:
- Migraine without aura according to the criteria of the International Classification of Headache Disorders (ICHD-3 beta)
- 1-4 days with migraine per month in the preceding last 3 months
- A score between 2 and 6 on a numeric rating scale for the intensity of interictal photophobia (range from 0 to 10 (= max. intensity))
- A score \>4 for ictal photophobia
- Controls
- No personal or family history of migraine
- A score \<2 for photophobia
Exclusion
- Current or previous circadian rhythm disorders
- Current or previous major depression
- Current or previous anxiety disorders
- Current or previous medication overuse
- Besides migraine in the patient group, participants should not suffer from any other recurrent headache apart from infrequent tension-type headaches
Key Trial Info
Start Date :
April 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT05369910
Start Date
April 1 2015
End Date
September 30 2019
Last Update
May 11 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.